Striving toward better health for individuals and progress in medicine.

As a wholly owned subsidiary of Takeda Pharmaceutical Company Limited, Takeda Pharmaceuticals North America, Inc. is among the top 15 pharmaceutical companies in the United States. TPNA was founded in 1998 to accelerate Takeda's global expansion into the U.S. market.

Takeda’s U.S. clinical development activities are conducted via Takeda Global Research & Development Center, Inc., which has a robust pipeline of compounds in multiple therapeutic areas including diabetes, cardiovascular disease, and gastroenterology.

Improving the lives of patients is at the center of everything we do. Takeda is enjoying tremendous growth as an emerging global leader in the pharmaceutical industry, but we remain ever mindful of our commitment to serve patients by striving toward better health for patients worldwide through leading innovation in medicine. The spirit of our commitment extends to our employees, partners and the larger community.